Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery

NCT01234532 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Estrogen Receptor-negative Breast Cancer
HER2-negative Breast Cancer
Progesterone Receptor-negative Breast Cancer
Stage I Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer
Triple-negative Breast Cancer

Interventions

DRUG: entinostat
DRUG: anastrozole
OTHER: diagnostic laboratory biomarker analysis
PROCEDURE: therapeutic conventional surgery

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]